Annals of Surgical Oncology

, Volume 10, Issue 4, pp 338–347 | Cite as

Radiofrequency Ablation of Malignant Liver Tumors

New Approaches to the Treatment of Hepatic Malignancies


Background: Radiofrequency ablation (RFA) is being used to treat primary and metastatic liver tumors. The indications, treatment planning, and limitations of hepatic RFA must be defined and refined by surgeons treating hepatic malignancies.

Methods: A review of the experience using RFA to treat unresectable primary and secondary hepatic malignancies at the University of Texas M. D. Anderson Cancer Center in Houston, Texas, and the G. Pascale National Cancer Institute in Naples, Italy, is provided. Patient selection, treatment approach, local recurrence rates, and overall cancer recurrence rates following RFA are described. The current literature on RFA of hepatic malignancies is reviewed.

Results: RFA of hepatic tumors can be performed percutaneously, laparoscopically, or during an open surgical procedure. Incomplete treatment manifest as local recurrence is more common with a percutaneous approach. The morbidity and mortality rates associated with hepatic RFA are low. Local recurrence rates are low if meticulous treatment planning is performed. RFA can be combined safely with partial hepatic resection of large lesions. The long-term survival rates following RFA of primary and metastatic liver tumors have not yet been established.

Conclusions: RFA of hepatic malignancies is a safe and promising technique to produce coagulative necrosis of unresectable hepatic malignancies. Experience with this treatment modality is not yet mature enough to establish long-term outcomes.

Key Words:

Radiofrequency ablation Liver cancer Coagulation necrosis Thermal ablation 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    LeVeen RF. Laser hyperthermia and radiofrequency ablation of hepatic lesions. Semin Interven Radiol 1997;14:313–24.Google Scholar
  2. 2.
    Dickson JA, Calderwood SK. Temperature range and selective sensitivity of tumors to hyperthermia: a critical review. Ann N Y Acad Sci 1980;335:180–205.PubMedCrossRefGoogle Scholar
  3. 3.
    Hill RP, Hunt JW. Hyperthermia Tannock IF, Hill RP Eds. The Basic Science of Oncology. New York: Pergamon Press, 1987: 337–57.Google Scholar
  4. 4.
    Haines DE, Watson DD, Halperin C. Characteristics of heat transfer and determination of temperature gradient and viability threshold during radiofrequency fulguration of isolated perfused canine right ventricle. Circulation 1987;76:278–82.Google Scholar
  5. 5.
    Grundfest WS, Litvack FI, Doyle DL. Laser-tissue interactions: considerations for cardiovascular applications White RA, Grundfest WS Eds. Lasers in Cardiovascular Disease. Chicago: Yearbook Medical Publishers, 1987: 32–43.Google Scholar
  6. 6.
    Bischof J, Christov K, Rubinsky B. A morphological study of cooling rate response in normal and neoplastic human liver tissue: cryosurgical implications. Cryobiology 1993;30:482–92.PubMedCrossRefGoogle Scholar
  7. 7.
    Steeves RA. Hyperthermia in cancer therapy: where are we today and where are we going? Bull N Y Acad Med 1992;68:341–50.PubMedGoogle Scholar
  8. 8.
    Siperstein AE, Rogers SJ, Hansen PD, Gitomirsky A. Laparoscopic thermal ablation of hepatic neuroendocrine tumor metastases. Surgery 1997;122:1147–54.PubMedCrossRefGoogle Scholar
  9. 9.
    Goldburg SN, Gazelle GS, Solbiati L. Ablation of liver tumors using percutaneous RF therapy. Am J Res 1998;170:1023–8.Google Scholar
  10. 10.
    Lencioni R, Goletti O, Armillotta N, et al. Radio-frequency thermal ablation of liver metastases with a cooled-tip electrode needle: results of a pilot clinical trial. Eur Radiol 1998;8:1205–11.PubMedCrossRefGoogle Scholar
  11. 11.
    Nagata Y, Hiraoka M, Nishimura Y, et al. Clinical results of radiofrequency hyperthermia for malignant liver tumors. Int J Radiat Oncol Biol Phys 1997;38:359–65.PubMedGoogle Scholar
  12. 12.
    McGahan JP, Brock JM, Tesluk H, Gu WZ, Schneider P, Browning PD. Hepatic ablation with use of radio-frequency electrocautery in the animal model. J Vasc Interv Radiol 1992;3:291–7.PubMedCrossRefGoogle Scholar
  13. 13.
    Curley SA, Izzo F, Delrio P, et al. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg 1999;230:1–8.PubMedCrossRefGoogle Scholar
  14. 14.
    Curley S, Izzo F, Ellis LM, Woodall M, Wolff R, Vauthey JN. Radiofrequency ablation of malignant liver tumors in 304 patients. Paper presented at: Proceedings ASCO; May 2000; New Orleans, LA.Google Scholar
  15. 15.
    Tuttle T. Hepatectomy for noncolorectal liver metastases Curley SA Eds. Liver Cancer. New York: Springer-Verlag Publishers, 1998: 201–11.Google Scholar
  16. 16.
    Curley SA, Davidson BS, Fleming RY, et al. Laparoscopically guided bipolar radiofrequency ablation of areas of porcine liver. Surg Endosc 1997;11:729–33.PubMedCrossRefGoogle Scholar
  17. 17.
    Curley SA, Izzo F, Ellis LM, Nicolas Vauthey J, Vallone P. Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg 2000;232:381–91.PubMedCrossRefGoogle Scholar
  18. 18.
    Patterson J, Strang R. The role of blood flow in hyperthermia. Int J Radiat Oncol Biol Phys 1979;5:235–41.PubMedGoogle Scholar
  19. 19.
    Kolios MC, Sherar MD, Hunt JW. Large blood vessel cooling in heated tissues: a numerical study. Phys Med Biol 1995;40:477–94.PubMedCrossRefGoogle Scholar
  20. 20.
    Sturesson C, Liu DL, Stenram U, Andersson-Engels S. Hepatic inflow occlusion increases the efficacy of interstitial laser-induced thermotherapy in rat. J Surg Res 1997;71:67–72.PubMedCrossRefGoogle Scholar
  21. 21.
    Curley SA. Radiofrequency ablation of malignant liver tumors. Oncologist 2001;6:14–23.PubMedCrossRefGoogle Scholar
  22. 22.
    Solbiati L, Ierace T, Tonolini M, Osti V, Cova L. Radiofrequency thermal ablation of hepatic metastases. Eur J Ultrasound 2001;13:149–58.PubMedCrossRefGoogle Scholar
  23. 23.
    Siperstein A, Garland A, Engle K, et al. Local recurrence after laparoscopic radiofrequency thermal ablation of hepatic tumors. Ann Surg Oncol 2000;7:106–13.PubMedCrossRefGoogle Scholar
  24. 24.
    Wood TF, Rose DM, Chung M, Allegra DP, Foshag LJ, Bilchik AJ. Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations, and complications. Ann Surg Oncol 2000;7:593–600.PubMedGoogle Scholar
  25. 25.
    Bowles BJ, Machi J, Limm WM, et al. Safety and efficacy of radiofrequency thermal ablation in advanced liver tumors. Arch Surg 2001;136:864–9.PubMedCrossRefGoogle Scholar
  26. 26.
    de Baere T, Elias D, Dromain C, et al. Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year. AJR Am J Roentgenol 2000;175:1619–25.PubMedGoogle Scholar
  27. 27.
    Siperstein AE, Berber E. Cryoablation, percutaneous alcohol injection, and radiofrequency ablation for treatment of neuroendocrine liver metastases. World J Surg 2001;25:693–6.PubMedCrossRefGoogle Scholar
  28. 28.
    Wessels FJ, Schell SR. Radiofrequency ablation treatment of refractory carcinoid hepatic metastases. J Surg Res 2001;95:8–12.PubMedCrossRefGoogle Scholar
  29. 29.
    Choi H, Loyer EM, Dubrow RA, et al. Radiofrequency ablation (RFA) of liver tumors: assessment of therapeutic response and complications. Radiographics 2001;21:S41–S54.PubMedGoogle Scholar
  30. 30.
    Catalano O, Lobianco R, Esposito M, Siani A. Hepatocellular carcinoma recurrence after percutaneous ablation therapy: helical CT patterns. Abdom Imaging 2001;26:375–83.PubMedCrossRefGoogle Scholar
  31. 31.
    Cioni D, Lencioni R, Bartolozzi C. Percutaneous ablation of liver malignancies: imaging evaluation of treatment response. Eur J Ultrasound 2001;13:73–93.PubMedCrossRefGoogle Scholar
  32. 32.
    Cedrone A, Pompili M, Sallustio G, Lorenzelli GP, Gasbarrini G, Rapaccini GL. Comparison between color power Doppler ultrasound with echo-enhancer and spiral computed tomography in the evaluation of hepatocellular carcinoma vascularization before and after ablation procedures. Am J Gastroenterol 2001;96:1854–9.PubMedCrossRefGoogle Scholar
  33. 33.
    Ravikumar TS, Jones M, Serrano M, Kaleya R, Valdivia A, Mil-stein DM. The role of PET scanning in radiofrequency ablation of liver metastasis from colorectal cancer. Cancer Journal 2000; 6(Suppl 4):S330–S43.Google Scholar
  34. 34.
    Donckier V, Luc Van Laethem J, Feron P, et all., Contribution of FDG positron emission tomography in the evaluation of the treatment of liver metastasis using radiofrequency ablation. (in press).Google Scholar

Copyright information

© The Society of Surgical Oncology, Inc. 2003

Authors and Affiliations

  1. 1.Department of Surgical OncologyThe University of Texas M. D. Anderson Cancer CenterHouston
  2. 2.M. D. Anderson Cancer Center, Department of Surgical OncologyUniversity of TexasHouston

Personalised recommendations